December 16, 2004

News & Opinion: Another drug industry headache

By: Dylan Schleicher @ 5:55 PM – Filed under: Management & Workplace Culture

This morning's news that Louisana congressman Billy Tauzin, chief architect of the new Medicaid drug law, has taken a job as the drug industry's top lobbyist will no doubt fuel more cynicism about the big drug companies. On the surface, it sure looks like a reward to Tauzin for a bill that critics thought was overly industry-friendly. He's getting blasted in the papers today. It's amazing, when you think about it, that the drug companies, which are truly miracle makers when it comes to their products, have become so widely disliked. Pricing's part of the problem. So are safety concerns. I haven't read it yet but I'm told the best book on this topic is The Truth About the Drug Companies by Marcia Angell, former editor of the New England Journal of Medicine. Someone should send a copy to Tauzin.

About Dylan Schleicher

Dylan Schleicher has been a part of the 800-CEO-READ claque since 2003. Even though he's stayed on at the company, he has not stayed put. After beginning in shipping & receiving, he joined customer service and accounting before moving into his current, highly elliptical orbit of duties overseeing the ChangeThis and In the Books websites, the company's annual review of books and in-house design. He lives with his wife and two children in the Washington Heights neighborhood on Milwaukee's West Side.